News

Bausch Health Companies reports $344M Q4 loss, revenue edges lower

Bausch Health Companies reports $344M Q4 loss, revenue edges lower
Business
On an adjusted basis, Bausch Health says it earned $368 million for the quarter compared with an adjusted profit of $347 million a year earlier.

Revenue totalled $2.12 billion for the quarter, down from $2.16 billion in the fourth quarter of 2017.

In its outlook for 2019, the company says it expects full year revenue in the range of $8.3 billion to $8.5 billion and adjusted earnings before interest, taxes, depreciation and amoritization in a range from $3.35 billion to $3.5 billion.
Read more on Toronto Star
News Topics :
Similar Articles :
Business
LAVAL, QUE. — Bausch Health Companies Inc. reported a loss of $350 million in its latest quarter as its revenue moved lower. The company formerly known as Valeant Pharmaceuticals says...
Business
The Quebec based drug company, which keeps its books in U.S. dollars, says the loss amounted to 15 cents per share compared with a loss of $2.58 billion or $7.36 per...
Business
MONTREAL—Bausch Health Companies Inc. posted a net loss of $873 million U.S. in the second quarter as the company formerly known as Valeant Pharmaceuticals experienced a bigger operating loss and...
Business
LAVAL, QUE.—Valeant Pharmaceuticals International says its second quarter loss was reduced dramatically to $38 million U.S. as the company progressed on its debt reduction and divestment programs. The loss amounted to 11...
Business
LAVAL, Que. Valeant Pharmaceuticals International TSX VRX says its second quarter loss was reduced dramatically to US$38 million as the company progressed on its debt reduction and divestment programs. The loss, reported...